Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Impact of HMGB1 Polymorphisms on Prostate Cancer Progression and Clinicopathological Characteristics.

International journal of environmental research and public health - 3 Oct 2020

Chou Ying-Erh, Yang Po-Jen, Lin Chia-Yen, Chen Yen-Yu, Chiang Whei-Ling, Lin Pei-Xuan, Huang Zih-Yun, Huang Matthew, Ho Yung-Chuan, Yang Shun-Fa

Abstract excerpt

Prostate cancer is one of the major cancers of the genitourinary tract. High-mobility group box 1 (HMGB1) was suggested as a promising therapeutic target for prostate cancer. In this study, we aim to elucidate the associations of HMGB1 single nucleotide polymorphisms (SNPs) with prostate cancer susceptibility and clinicopathological characteristics. The HMGB1 SNPs rs1412125, rs2249825, rs1045411, and rs1360485 in...

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Disease Progression
Share to Genetic Predisposition to Disease
Share to Genotype
Share to HMGB1 Protein
Share to Polymorphism, Single Nucleotide
Share to Prostatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 33023053
DOI: 10.3390/ijerph17197247
PMCID: PMC7579148

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Impact of HMGB1 Polymorphisms on Prostate Cancer Progression and Clinicopathological Characteristics.PMID 33023053Read ↗

Effect of HMGB1 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathological CharacteristicsSemantic proximity Read ↗

High-mobility group box 1 protein (HMGB1) gene polymorphisms and cancer susceptibility: A comprehensive meta-analysis.Semantic proximity Read ↗

HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer.Semantic proximity Read ↗

Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma.Semantic proximity Read ↗

Meta-analysis of the association between the HNF1B rs4430796 (A>G) polymorphism and risk of prostate cancer based on case-control studies.Semantic proximity Read ↗

Role of HMGB1 and its associated signaling pathways in human malignanciesSemantic proximity Read ↗

Association of HMGB1 Gene Polymorphisms with Lung Cancer Susceptibility and Clinical Aspects.Semantic proximity Read ↗

No association between HMGB1 polymorphisms and cancer risk: evidence from a meta-analysis.Semantic proximity Read ↗

Single Nucleotide Polymorphisms in HMGB1 Correlate with Lung Cancer Risk in the Northeast Chinese Han Population.Semantic proximity Read ↗

Association of Homeobox B13 (HOXB13) Gene Variants with Prostate Cancer Risk in Iranian PopulationSemantic proximity Read ↗

Exploratory Analysis of HMGB1 Genetic Variants and Their Potential Association with Lung Cancer Susceptibility and Chemotherapy Response in a Chinese Population.Semantic proximity Read ↗

Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.